GeekWire: Gates Foundation awards $800K grant to A-Alpha Bio for COVID-19 treatment research

A-Alpha Bio, a biotechnology startup that partners with pharmaceutical companies to accelerate drug development with multiplexed measurements of protein interactions, today announced that it had been awarded an $800,000 grant to optimize therapeutics for infectious diseases.


Geekwire's Lisa Stiffler wrote an article discussing the details of the award, and how the AlphaSeq platform used in conjunction with machine learning can help create drugs to treat infectious diseases.

Copyright  ©  2020  A-Alpha Bio, Inc. - All Rights Reserved